These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33821664)

  • 61. Biotherapies in stroke.
    Detante O; Jaillard A; Moisan A; Barbieux M; Favre IM; Garambois K; Hommel M; Remy C
    Rev Neurol (Paris); 2014 Dec; 170(12):779-98. PubMed ID: 25459115
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stem Cell Therapy for Congenital Heart Disease: A Systematic Review.
    Tsilimigras DI; Oikonomou EK; Moris D; Schizas D; Economopoulos KP; Mylonas KS
    Circulation; 2017 Dec; 136(24):2373-2385. PubMed ID: 29229621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improvement of Local Cell Delivery Using Helix Transendocardial Delivery Catheter in a Porcine Heart.
    Mitsutake Y; Pyun WB; Rouy D; Foo CWP; Stertzer SH; Altman P; Ikeno F
    Int Heart J; 2017 May; 58(3):435-440. PubMed ID: 28539564
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intraperitoneal injection (IP), Intravenous injection (IV) or anal injection (AI)? Best way for mesenchymal stem cells transplantation for colitis.
    Wang M; Liang C; Hu H; Zhou L; Xu B; Wang X; Han Y; Nie Y; Jia S; Liang J; Wu K
    Sci Rep; 2016 Aug; 6():30696. PubMed ID: 27488951
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stem cell engineering for treatment of heart diseases: potentials and challenges.
    Li SC; Wang L; Jiang H; Acevedo J; Chang AC; Loudon WG
    Cell Biol Int; 2009 Mar; 33(3):255-67. PubMed ID: 19084605
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy.
    Selvakumar D; Clayton ZE; Chong JJH
    Clin Ther; 2020 Oct; 42(10):1857-1879. PubMed ID: 32943195
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stem cell-based therapy: Improving myocardial cell delivery.
    Feyen DAM; Gaetani R; Doevendans PA; Sluijter JPG
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):104-115. PubMed ID: 27133386
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Repeated Cell Therapy: A Paradigm Shift Whose Time Has Come.
    Bolli R
    Circ Res; 2017 Mar; 120(7):1072-1074. PubMed ID: 28179431
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mesenchymal stem cell administration at coronary artery reperfusion in the rat by two delivery routes: a quantitative assessment.
    Hale SL; Dai W; Dow JS; Kloner RA
    Life Sci; 2008 Sep; 83(13-14):511-5. PubMed ID: 18755200
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cell therapy for heart disease: current status and future directions.
    Kahlon A; Vaidya G; Bolli R
    Minerva Cardioangiol; 2018 Jun; 66(3):273-291. PubMed ID: 29327894
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Concise Review: Heart-Derived Cell Therapy 2.0: Paracrine Strategies to Increase Therapeutic Repair of Injured Myocardium.
    Rafatian G; Davis DR
    Stem Cells; 2018 Dec; 36(12):1794-1803. PubMed ID: 30171743
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Direct somatic cell reprogramming: treatment of cardiac diseases.
    Guo C; Patel K; Qian L
    Curr Gene Ther; 2013 Apr; 13(2):133-8. PubMed ID: 23320478
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exploitation of stem cell homing for gene delivery.
    Penn MS; Khalil MK
    Expert Opin Biol Ther; 2008 Jan; 8(1):17-30. PubMed ID: 18081534
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardiac regeneration - Past advancements, current challenges, and future directions.
    Pezhouman A; Nguyen NB; Kay M; Kanjilal B; Noshadi I; Ardehali R
    J Mol Cell Cardiol; 2023 Sep; 182():75-85. PubMed ID: 37482238
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cardiac stem cell therapy: stemness or commitment?
    Mehta A; Shim W
    Cell Transplant; 2013; 22(1):1-14. PubMed ID: 22943934
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The current state of stem cell therapeutics: Canadian approaches in the international context.
    Noiseux N; Marquis-Gravel G; Mansour S; Shahzad U; Stewart DJ; Yau TM
    Can J Cardiol; 2014 Nov; 30(11):1361-9. PubMed ID: 25249498
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cardiac biointerventions: whatever happened to stem cell and gene therapy?
    Rosengart TK; Fallon E; Crystal RG
    Innovations (Phila); 2012; 7(3):173-9. PubMed ID: 22885457
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stem Cell Therapy and Administration Routes After Stroke.
    Rodríguez-Frutos B; Otero-Ortega L; Gutiérrez-Fernández M; Fuentes B; Ramos-Cejudo J; Díez-Tejedor E
    Transl Stroke Res; 2016 Oct; 7(5):378-87. PubMed ID: 27384771
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Intramyocardial delivery of FGF2 in combination with radio frequency transmyocardial revascularization.
    Bao J; Naimark W; Palasis M; Laham R; Simons M; Post MJ
    Catheter Cardiovasc Interv; 2001 Jul; 53(3):429-34. PubMed ID: 11458429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.